Photo of Robert Y. Maples˘

Robert Y. Maples is experienced in the Washington, D.C. federal, state and public affairs arenas. He has also been an advocate for building pragmatic alliances to resolve major social issues and has pioneered strategies for addressing complex public affairs crises in collaborative versus confrontational contexts. He continues his advocacy of pragmatic alliances in furtherance of client/government collaborations among the Congress and federal agencies, and serves as state counsel on complex client public policy matters. He is experienced in complex problem solving in regulatory and legislative environments and his client interests have led to Food and Drug Administration (FDA) activities and cybersecurity representation.

˘ Not admitted to practice law.

As the state deadline for bill signings approached, Virginia Governor Ralph Northam announced many legislative signings on April 12.  In proposing amendments and executing these bills, the governor referenced the Coronavirus Disease 2019 (COVID-19) pandemic and taking action to help Virginia workers address the current crisis as well as plan for economic recovery.

Governor Northam…

On Feb. 7, the White House Opportunity and Revitalization Council released a report to President Trump demonstrating the impact of opportunity zones across America. The 157-page report comprehensively addresses many metrics suggested and achieved by opportunity zones to date, and makes two legislative suggestions to Congress to improve zone impact:

“1) In order to measure…

The U.S. Mayors convened their 88th Washington, D.C. Winter Meeting and released the 2019 Menino Survey of Mayors, the sixth such survey, reflecting the views of 119 mayors of cities with populations at or above 75,000 residents. The 2019 survey was somewhat unique in that the mayors were surveyed about Opportunity Zones, a federal…

After receiving Senate confirmation for an undersecretary position earlier in the day, Chad Wolf was sworn in and placed as the next Acting Secretary of the Department of Homeland Security (DHS). Since January 2017, there has been a mix of Senate-confirmed secretaries: John Kelly and Kristjen Nielsen; and acting secretaries: Elaine Duke, Kevin McAleenan, and…

On Friday, Nov. 1, and as discussed in a previous Hot Off the Hill blog post, President Trump nominated Dr. Stephen Hahn, Chief Executive of the MD Anderson Cancer Center, for FDA Commissioner.

HHS Secretary Alex Azar also announced leadership changes to complement the president’s announcement.

This action brings significant executive leadership change into…

On Oct. 17 a fiery debate occurred on the U.S. Senate floor. Two great supporters of immigrants and immigration reform, Senators Dick Durbin (D-IL, Minority Floor Leader) and Mike Lee (R-UT, Chairman, Senate Judiciary Subcommittee on Antitrust) battled to a draw on an issue they both support – eliminating the per-country caps on employment-based…

Due to federal rules applicable to “acting” agency heads, the current FDA Acting Commissioner, Ned Sharpless, or another person, should be nominated to be FDA Commissioner by month’s end. In order to be named FDA Commissioner, Senate confirmation is required.

This is a critical time for FDA as they face the ongoing fiscal…